In our report, multivariate analysis adjusting histologic grade and tumor stage, AQP5 expression status among all stages of BC patients seems to be an independent molecular marker associated with worse clinical outcomes and this observation seems to be like Lee et al.’s [23] analysis among early-stage breast cancer patients. This evidence concerns the gene AQP5 and breast cancer.